Anavex has announced significant findings from its phase 2b/3 trial of blarcamesine, an investigational treatment for early Alzheimer’s disease. The results indicate a notable reduction […]

Anavex Life Sciences, a New York-based biopharmaceutical powerhouse, has been making strides in the development of novel treatments for life-altering neurological conditions. As a leading […]

No one can escape the process of aging, but successful investor Jason Hope predicts technology will play an integral part in changing the way we […]